This patent, entitled Glucosamine and Method of Making Glucosamine from Microbial Biomass, represents the latest improvements to Cargill’s non-shellfish glucosamine production processes.
Mark Christiansen, Cargill Corn Milling North America, said: “Cargill continues to pursue innovations for its glucosamine products and processes. We are committed to producing safe, quality consistent Regenasure glucosamine at our state of the art facility in Eddyville, Iowa.”
This patent describes a unique glucosamine composition formed from a vegetarian-based material, as well as a kosher fungal biomass-derived glucosamine suitable for human consumption.
Cargill’s Regenasure glucosamine is the only US produced, Generally Recognised As Safe (GRAS) glucosamine commercially available which is also suitable for vegetarians and those with shellfish allergies.
Cargill has neither licensed nor authorised any other parties to produce glucosamine utilising the technology covered under patent #8,034,925.
The US Patent and Trademark office also issued patent #7,816,514 to Cargill for additional features of its glucosamine technology.
Source: Cargill
© FoodBev Media Ltd 2024